n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea has been researched along with Muscle Weakness in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Attaix, D; Cardenas, DM; Cervek, M; Combaret, L; Debiton, E; Le Bricon, T; Madelmont, JC; Pouch, MN; Samuels, SE; Taillandier, D; Temparis, S; Tilignac, T | 1 |
1 other study(ies) available for n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea and Muscle Weakness
Article | Year |
---|---|
Chemotherapy inhibits skeletal muscle ubiquitin-proteasome-dependent proteolysis.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cachexia; Cisplatin; Colonic Neoplasms; Cysteine Endopeptidases; Female; Ifosfamide; Male; Mice; Mice, Inbred BALB C; Multienzyme Complexes; Muscle Proteins; Muscle Weakness; Muscle, Skeletal; Nitrosourea Compounds; Proteasome Endopeptidase Complex; Rats; Rats, Inbred F344; RNA, Messenger; Ubiquitin | 2002 |